2026 NPPES data Dermatology Physician NPI 1154465540 M.D., PH.D.
Verify on CMS →

ANTHONY CUKRAS, M.D., PH.D.

Dermatology Physician in BOSTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 476 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: ANTHONY CUKRAS, M.D., PH.D. is a Dermatology Physician ([object Object]) practicing in BOSTON, Massachusetts with a Medicare Part D prescribing footprint of 1K claims across 476 beneficiaries — 19% brand-name prescribing .

What stands out: ANTHONY CUKRAS, M.D., PH.D. filed 1,373 Medicare Part D claims in 2023 across BOSTON, Massachusetts. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

ANTHONY CUKRAS, M.D., PH.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

ANTHONY CUKRAS, M.D., PH.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 02/18/2007

NPI 1154465540

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

1,373 88% vs specialty avg

2023 prescription claims

Specialty avg: 729

Specialty distribution in Massachusetts

How Dermatology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Dermatology Physician share within Massachusetts

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Dermatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Dermatology Physician ABMS/AOA estimate

Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANTHONY CUKRAS, M.D., PH.D. is a Dermatology Physician provider practicing in BOSTON, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D., PH.D.. NPI: 1154465540. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ANTHONY CUKRAS, M.D., PH.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D., PH.D. credentials at 330 BROOKLINE AVE, BOSTON, MA, 02215, with a listed phone of (617) 667-3753. NPI 1154465540 was issued on 02/18/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CUKRAS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,373 prescription claims written by this provider, covering 476 Medicare beneficiaries and totaling roughly $965K in drug spend, split 19% brand-name and 81% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

330 BROOKLINE AVE
BOSTON, MA 02215

Provider Details

NPI 1154465540
Specialty Dermatology Physician
Credentials M.D., PH.D.
Gender Male
NPI Issued 02/18/2007

Hospital and facility affiliations

Facilities where ANTHONY CUKRAS, M.D., PH.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

HARVARD MEDICAL FACULTY PHYS AT BETH ISRAEL DEACONESS MED CTR INC
NEEDHAM, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to ANTHONY CUKRAS, M.D., PH.D.. To verify ANTHONY CUKRAS, M.D., PH.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ANTHONY CUKRAS, M.D., PH.D. — brand share 19.0%
Specialty average (est.)

19% brand-name claims vs 81% generic, on 1,373 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,373
Total Claims
$965K
Total Drug Cost
476
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,658
Total Day Supply
46,464
Brand vs Generic
19% brand / 81% generic
Brand Drug Cost
$878K
Generic Drug Cost
$87K
Antibiotic Claims
20

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
1.32
Gender Split
48% female / 52% male
Age Distribution
<65: 55, 65-74: 204, 75-84: 166, 85+: 51

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ketoconazole
138
Triamcinolone Acetonide
135
Dupixent Pen
Dupilumab
105
Fluorouracil
98
Clobetasol Propionate
75
Hydrocortisone
67
Betamethasone Diprop Augmented
Betamethasone/Propylene Glyc
64
Ammonium Lactate
62
Tacrolimus
61
Minoxidil
47

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How ANTHONY CUKRAS, M.D., PH.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

ANTHONY CUKRAS, M.D., PH.D.'s 1,373 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as CUKRAS.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANTHONY CUKRAS, M.D., PH.D.'s specialty?
ANTHONY CUKRAS, M.D., PH.D. specializes in Dermatology Physician and practices in BOSTON, Massachusetts. Credentials: M.D., PH.D..
How much does ANTHONY CUKRAS, M.D., PH.D. prescribe under Medicare Part D?
In 2023, ANTHONY CUKRAS, M.D., PH.D. wrote 1,373 Medicare Part D claims totaling $965K in drug costs for 476 beneficiaries.
Where is ANTHONY CUKRAS, M.D., PH.D. located?
ANTHONY CUKRAS, M.D., PH.D. is located at 330 BROOKLINE AVE, BOSTON, MA, 02215. Phone: (617) 667-3753.
What is ANTHONY CUKRAS, M.D., PH.D.'s NPI number?
ANTHONY CUKRAS, M.D., PH.D.'s National Provider Identifier (NPI) is 1154465540, issued on 02/18/2007.
Does ANTHONY CUKRAS, M.D., PH.D. prescribe more brand-name or generic drugs?
ANTHONY CUKRAS, M.D., PH.D.'s prescribing is 19% brand-name and 81% generic drugs by claim count, with $878K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does ANTHONY CUKRAS, M.D., PH.D. prescribe most often?
Based on 2023 Medicare Part D data, ANTHONY CUKRAS, M.D., PH.D.'s most frequently prescribed drugs include Ketoconazole, Triamcinolone Acetonide, Dupixent Pen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANTHONY CUKRAS, M.D., PH.D. accept Medicare?
ANTHONY CUKRAS, M.D., PH.D. appears in CMS Medicare data with 1,373 Part D claims and 476 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANTHONY CUKRAS, M.D., PH.D.'s credentials?
ANTHONY CUKRAS, M.D., PH.D.'s NPI is 1154465540 with credentials M.D., PH.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology